In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Kyowa Hakko to pay £292mm for spec pharma ProStrakan

Executive Summary

Kirin Holdings Co. Ltd.’s pharma group Kyowa Hakko Kirin Co. Ltd. is attempting to acquire public Scottish company ProStrakan Group PLC for £292mm ($473mm) in cash. Kyowa will pay £1.30 per share, a 31% premium to the ten-day average prior to November 12, 2010, when ProStrakan began its offer period. ProStrakan said it had received bids from several suitors over the past few months, including an unsolicited £1-per-share offer from Norgine.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies